General
Pharmaceutical company Pfizer asks US regulators to allow emergency use of its experimental COVID-19 vaccine
Pharmaceutical company Pfizer has formally asked US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month.
Key points:
- How much vaccine is available and when is a moving target, but initial supplies will be scarce
- Globally, Pfizer has estimated it could have 50 million doses available by year’s end
- The US Government has a contract to buy millions of Pfizer-BioNTech doses
The action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appeared 95 per cent effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
The companies said protection plus a good safety record meant the vaccine…
-
General14 hours agoVote counting begins for Townsville mayoral by-election
-
Business24 hours agoWhat $10,000 invested in CBA shares could be worth in 12 months
-
Noosa News20 hours agoQueensland GPs to be able to diagnose adults with attention deficit hyperactivity disorder from December 1
-
Noosa News22 hours agoTrump reverses course on beef tariff as pressure builds over cost of living